Cargando…
Novel Synthetic Opioids: The Pathologist’s Point of View
Background: New Psychoactive Substances (NPS) constitute a broad range of hundreds of natural and synthetic drugs, including synthetic opioids, synthetic cannabinoids, synthetic cathinones, and other NPS classes, which were not controlled from 1961 to 1971 by the United Nations drug control conventi...
Autores principales: | Frisoni, Paolo, Bacchio, Erica, Bilel, Sabrine, Talarico, Anna, Gaudio, Rosa Maria, Barbieri, Mario, Neri, Margherita, Marti, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162684/ https://www.ncbi.nlm.nih.gov/pubmed/30200549 http://dx.doi.org/10.3390/brainsci8090170 |
Ejemplares similares
-
Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System
por: Frisoni, Paolo, et al.
Publicado: (2023) -
Pharmacological and Behavioral Effects of the Synthetic Cannabinoid AKB48 in Rats
por: Bilel, Sabrine, et al.
Publicado: (2019) -
Pharmaco-Toxicological Effects of Atypical Synthetic Cathinone Mephtetramine (MTTA) in Mice: Possible Reasons for Its Brief Appearance over NPSs Scene
por: Corli, Giorgia, et al.
Publicado: (2023) -
Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones
por: Mazdai, Leila, et al.
Publicado: (2022) -
Genotoxic Properties of Synthetic Cannabinoids on TK6 Human Cells by Flow Cytometry
por: Lenzi, Monia, et al.
Publicado: (2020)